Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 1/2018

01-01-2018 | White Paper

ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management

Authors: Marvin Ryou, Kenneth R. McQuaid, Christopher C. Thompson, Steven Edmundowicz, Klaus Mergener, ASGE EndoVators Task Force

Published in: Obesity Surgery | Issue 1/2018

Login to get access

Excerpt

On November 20 and 21, 2016, the American Society for Gastrointestinal Endoscopy (ASGE) and the Association for Bariatric Endoscopy (ABE) hosted the EndoVators Summit at the Institute for Training and Technology in Downers Grove, Illinois to define the role and value of endoscopic therapies in obesity management. Nearly 100 obesity management experts, innovators, and key decision makers from industry, insurers, and regulatory agencies gathered to review the current state of the obesity epidemic in America and the role that endoscopic bariatric and metabolic therapies (EBMTs) could play in the management of this chronic disease. Additionally, ASGE invited leaders of societies with an interest in EBMTs to participate in an exchange of ideas related to the training, research, and education in EBMTs with the goal of identifying areas of cooperation and coordination. The following societies were represented:
  • American Society for Gastrointestinal Endoscopy
  • The Association for Bariatric Endoscopy
  • American Society for Metabolic and Bariatric Surgery
  • International Federation for the Surgery of Obesity and Metabolic Disorders
  • The Obesity Society
  • American Association for the Study of Liver Diseases
  • American Society of Transplantation
  • American College of Gastroenterology
  • Academy of Nutrition and Dietetics
  • North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition
  • Society of American Gastrointestinal and Endoscopic Surgeons
…
Literature
1.
Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–1.CrossRefPubMed
2.
3.
Ogden CL, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief. 2015;219:1–8.
4.
Ogden CL, Lamb M, Carroll M, et al. Obesity and socioeconomic status in adults: United States, 2005-2008. NCHS Data Brief. 2010;50:1–8.
5.
6.
Finkelstein E, Trogdon J, Cohen J, et al. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff. 2009;28:w822–31.CrossRef
7.
Arterburn DE, Maciejewski M, Tsevat J. Impact of morbid obesity on medical expenditures in adults. Int J Obes. 2005;29:334–9.CrossRef
8.
Centers for Disease Control and Prevention (CDC). Adverse childhood experiences reported by adults—five states, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:1609–13.
9.
Fellitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The adverse childhood experiences (ACE) study. Am J Prev Med. 1998;14:245–58.CrossRef
10.
Lodhia NA, Rosas U, Moore M, et al. Do adverse childhood experiences affect surgical weight loss outcomes? J Gastrointest Surg. 2015;19:993–8.CrossRefPubMed
11.
Bray GA. Obesity illustrated. In: An atlas of obesity and weight control. New York: Parthenon Publishing; 2003. p. 79.
12.
13.
Nielsen SJ, Popkin BM. Patterns and trends in food portion sizes, 1977-1998. JAMA. 2003;189:450–3.CrossRef
14.
Powell E. Recent trends in added sugar intake among U.S. children and adults from 1977 to 2010. Poster abstract presented at: The Obesity Society Annual Meeting at Obesity Week 2014; November 2–7, 2014; Boston.
15.
Hu FB, Lee TY, Colditz GA, et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289:1785–91.CrossRefPubMed
16.
Ladabaum U, Mannalithara A, Myer PA, et al. Obesity, abdominal obesity, physical activity, and caloric intake in US adults: 1988 to 2010. Am J Med. 2014;127:717–27.CrossRefPubMedPubMedCentral
17.
Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science. 2005;307:1909–14.CrossRefPubMed
18.
Korner J, Leibel RL. To eat or not to eat—how the gut talks to the brain. N Engl J Med. 2003;349:926–8.CrossRefPubMed
19.
Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368:1696–705.CrossRefPubMed
20.
Siegel KR, McKeever B, Imperatore G, et al. Association of higher consumption of foods derived from subsidized commodities with adverse cardiometabolic risk among US adults. JAMA Intern Med. 2016;176:1124–32.CrossRefPubMed
21.
Seligman HK, Schillinger D. Hunger and socioeconomic disparities in chronic disease. N Engl J Med. 2010;363:6–9.CrossRefPubMed
22.
23.
24.
Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA. 2002;288:475–82.CrossRefPubMed
25.
Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis. 2014;56:465–72.CrossRefPubMed
26.
Price JH, Desmond SM, Krol RA, et al. Family practice physicians’ beliefs, attitudes, and practices regarding obesity. Am J Prev Med. 1987;3:339–45.PubMed
27.
Hill JO, Wyatt H. Outpatient management of obesity: a primary care perspective. Obes Res. 2002;10(suppl):124S–30S.CrossRefPubMed
28.
Moyer VA, U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157:378.
29.
Lefevre MLS, U.S. Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;161:587–93.CrossRefPubMed
30.
Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity: executive summary. Endocr Pract. 2016;22:842–84.CrossRefPubMed
31.
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77.CrossRefPubMed
32.
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63:2985–3023.CrossRefPubMed
33.
Apovian CM, Arrone LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342–62.CrossRefPubMed
34.
35.
36.
Wadden TA, Webb VL, Moran CH, et al. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125:1157–70.CrossRefPubMedPubMedCentral
37.
Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.CrossRef
38.
Dombrowski SU, Knittle K, Avenell A, et al. Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomized controlled trials. BMJ. 2014;348:g2646.CrossRefPubMedPubMedCentral
39.
Hamdy O, Carver C. The why WAIT program: improving clinical outcomes through weight management in type 2 diabetes. Curr Diab Rep. 2008;8:413–20.CrossRefPubMed
40.
Hamdy O, Mottalib A, Morsi A, et al. Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study. BMJ Open Diabetes Res Care. 2017;5(1):e000259.CrossRefPubMedPubMedCentral
41.
Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRefPubMed
42.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.CrossRefPubMed
43.
Diamantis T, Apostolou KG, Alexandrou A, et al. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10:177–83.CrossRefPubMed
44.
Young MT, Gebhart A, Phelan MJ, et al. Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surg. 2015;220:880–5.CrossRefPubMed
45.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3 year outcomes. N Engl J Med. 2014;370:2002–13.CrossRefPubMedPubMedCentral
46.
National Institute for Health and Care Excellence. Obesity: identification, assessment and management of overweight and obesity in children, young people and adults: partial update of CG43. National Clinical Guideline Centre, 2014.
47.
Cohen R, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35:1420–8.CrossRefPubMedPubMedCentral
48.
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23.PubMed
49.
ASGE Bariatric Endoscopy Task Force, ASGE Technology Committee, Abu Dayyeh BK, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–38.CrossRef
50.
Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943–53.CrossRefPubMed
51.
A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis 2011;7:672–682.
52.
Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11:874–81.CrossRefPubMed
53.
Sullivan S, Swain JM, Woodman G, et al. The Obalon swallowable 6-month balloon system is more effective than moderate intensity lifestyle therapy alone: results from a 6-month randomized sham controlled trial. Gastroenterology. 2016;150(4 suppl 1):S126.
54.
Thompson CC, Abu Dayyeh BK, Kushner R, et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol. 2017;112:447–57.CrossRefPubMed
55.
Lopez-Nava G, Sharaiha RZ, Galvao Neto M, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 242 patients with 18 months follow-up. Gastroenterology. 2016;150(4 suppl 1):S26.CrossRef
56.
Sullivan S, Swain JM, Woodman G, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity. 2017;25:294–301.CrossRefPubMed
57.
Mingrone G, Panuzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577–1585.
58.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–51.CrossRefPubMedPubMedCentral
59.
Nauck M, Stockmann F, Ebert R, et al. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia. 1986;29:46–52.CrossRefPubMed
60.
Rodriguez L, Reyes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther. 2009;11:725–32.CrossRefPubMed
61.
Koehestanie P, de Jonge C, Berends FJ, et al. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg 2014;260:984–992.
62.
Rajagopalan H, Cherington AD, Thompson CC, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care. 2016;39:2254–61.CrossRefPubMed
63.
Machytka E, Buzga M, Ryou M, et al. Endoscopic dual-path enteral bypass using a magnetic incisionless anastomosis system (IAS). Gastrointest Endosc. 2016;83:AB196.CrossRef
64.
Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013;20:377–88.CrossRefPubMedPubMedCentral
65.
MacLean PS, Wing RR, Davidson T, et al. NIH working group report: innovative research to improve maintenance of weight loss. Obesity. 2015;23:7–15.CrossRefPubMed
Metadata
Title
ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management
Authors
Marvin Ryou
Kenneth R. McQuaid
Christopher C. Thompson
Steven Edmundowicz
Klaus Mergener
ASGE EndoVators Task Force
Publication date
01-01-2018
Publisher
Springer US
Published in
Obesity Surgery / Issue 1/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2948-3

Other articles of this Issue 1/2018

Obesity Surgery 1/2018 Go to the issue

Original Contributions

Performance of the DiaRem Score for Predicting Diabetes Remission in Two Health Systems Following Bariatric Surgery Procedures in Hispanic and non-Hispanic White Patients

Original Contributions

Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Patients with Morbid Obesity and Normal Thyroid Function

Original Contributions

Health and Nutritional Status of Vegetarian Candidates for Bariatric Surgery and Practical Recommendations

Original Contributions

Inversion Technique for the Removal of Partially Covered Self-Expandable Metallic Stents

Original Contributions

Laparoscopic Ileal Interposition with Diverted Sleeve Gastrectomy Versus Laparoscopic Transit Bipartition with Sleeve Gastrectomy for Better Glycemic Outcomes in T2DM Patients

Original Contributions

Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease